Capricor Therapeutics | CAPR - Interest Expense On Debt


Capricor Therapeutics reported 581K in Interest Expense on Debt for its fiscal quarter ending in December of 2024.





Interest Expense On Debt Change Date
Bioline Rx USD 360K 84K Sep/2025
Capricor Therapeutics 581K 581K Dec/2024
Cipla INR 140.3M 8.5M Dec/2025
Cytokinetics USD 26.32M 2.06M Sep/2025
Geron USD 8.64M 128K Sep/2025
Grifols EUR 156.07M 31.46M Sep/2025
Immunic 400K 400K Dec/2024
J&J USD 18M 290M Sep/2025
Prothena USD 352.63M 46.44M Sep/2025
PTC Therapeutics USD 2.64B 2.61B Sep/2025
Sarepta Therapeutics USD 7.56M 2.33M Sep/2025